Antibiotics for Pneumocystis Pneumonia

All categories
DBCAT005155Pharmacologic class

Antibiotic agents that may be used for the treatment of, or prophylaxis against, pneumocystis pneumonia caused by Pneumocystis jirovecii (also known as Pneumocystis carinii). A DrugBank category of 8 drugs. 8 of them are approved.

Part of
Anti-Infective Agents
Drugs

What you can answer from here — as of April 22, 2020

8DrugsEach linked to its full drug card
Listed above
29Drug targetsEvery drug–target pair in the class, with bond type
Sign in
2,666Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
12Routes of administrationHow the drugs in this class are given
Sign in
1ReferenceSupporting the category definition
Sign in

Which targets do Antibiotics for Pneumocystis Pneumonia share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In